ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Adamson, Henney Chair Silicone Task Force

April 25, 1992

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

Trials Approved by NCI CTEP For the Month of April

April 27, 2012